We also compared the anti-cervical cancer cell activity of SKI-V with other known SphK inhibitors, including SKI-II 57-59, FTY720 60, 61 and the SphK2 specific inhibitor ABC294640 18, 19, 62. This evidence concerns the gene SPHK1 and cervical carcinoma.